Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Illuminated Chopper in Cataract Surgery (IChopper)

28 settembre 2026 aggiornato da: YES Eye Clinic

Prospective Randomized, Paired-Eye, Comparative Study Between Cataract Surgeries With and Without an Illuminated Chopper

This study compares cataract surgery performed with an illuminated chopper and intracameral illumination with cataract surgery performed under conventional external coaxial microscope illumination. Participants undergoing bilateral cataract surgery will have one eye treated with the illuminated chopper and the other eye treated without the illuminated chopper, with the order randomized between eyes.

The study will evaluate differences in operation time, pupil size, the need for additional intraocular medications or devices, intraoperative and postoperative complications, and postoperative clinical outcomes including visual acuity and intraocular pressure.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

This is a prospective, randomized, paired-eye comparative clinical study in participants undergoing bilateral cataract surgery. Each participant will undergo cataract surgery in both eyes. One eye will be treated using the iChopper illumination chopper with the iVision light source, while the fellow eye will undergo cataract surgery using conventional external coaxial microscope illumination. The order of the surgical method between the right and left eyes will be randomized.

The illuminated chopper provides intracameral illumination during cataract surgery and is designed to improve visualization of intraocular structures while also functioning as a lens chopper. The investigational device has received U.S. FDA 510(k) clearance.

The study will assess intraoperative outcomes including operation time, pupil size, ultrasound usage time, pupil-related surgical difficulties, intraoperative complications, and the use of additional intraocular medications or devices. Postoperative assessments will include visual acuity, manifest refraction, intraocular pressure, and postoperative complications.

Participants will undergo bilateral cataract surgery with the two procedures scheduled approximately 1 to 3 weeks apart. Follow-up assessments will be performed approximately 1 day and 30 days after surgery for each eye.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

28

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Florida
      • Cape Coral, Florida, Stati Uniti, 33904
        • Tyson Eye

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

40 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Age 40 years or older
  • Diagnosis of bilateral cataract
  • Both eyes suitable for cataract surgery
  • Expected postoperative best-corrected visual acuity of 0.2 Snellen or better
  • No other secondary ocular surgeries planned during the study period
  • Ability to comply with all study procedures and follow-up visits
  • Ability and willingness to provide written informed consent

Exclusion Criteria:

  • Preoperative ocular or systemic conditions, or medication use, that may affect study outcomes, increase risk to the participant, or predispose to complications, including infectious disease, ocular atrophy, or zonular weakness
  • Poorly controlled diabetes mellitus
  • Use of alpha-blockers such as tamsulosin for benign prostatic hyperplasia
  • Planned femtosecond laser-assisted cataract surgery
  • Congenital ocular disorders
  • History of ophthalmic surgery in either eye that may affect study outcomes or increase risk, including retinal surgery, glaucoma surgery, or anterior segment surgery
  • Inability to provide informed consent
  • Pregnancy

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Illuminated Chopper in Right Eye

Participants assigned to this arm undergo cataract surgery using the illuminated chopper in the right eye and cataract surgery under conventional external coaxial microscope illumination in the left eye.

Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification.

Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper.

Sperimentale: Illuminated Chopper in Left Eye

Participants assigned to this arm undergo cataract surgery under conventional external coaxial microscope illumination in the right eye and cataract surgery using the illuminated chopper in the left eye.

Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification.

Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Operation Time
Lasso di tempo: During cataract surgery

Operation time during cataract surgery will be recorded and compared between eyes undergoing surgery with the illuminated chopper and eyes undergoing surgery with conventional microscope illumination.

During cataract surgery
Pupil Size During Cataract Surgery
Lasso di tempo: During cataract surgery

Pupil size during cataract surgery will be assessed and compared between the illuminated chopper and conventional microscope illumination conditions.

During cataract surgery
Use of Additional Intraocular Medications
Lasso di tempo: During cataract surgery

The use of additional intraocular medications during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions.

During cataract surgery
Use of Additional Intraocular Devices
Lasso di tempo: During cataract surgery

The use of additional intraocular devices during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions.

During cataract surgery

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Intraoperative Complications
Lasso di tempo: During cataract surgery

Intraoperative complications occurring during cataract surgery, including pupil-related and other surgical complications, will be recorded and compared between the two surgical conditions.

During cataract surgery
Postoperative Complications
Lasso di tempo: From surgery through approximately 30 days after surgery

Postoperative complications following cataract surgery will be recorded and compared between eyes treated with and without the illuminated chopper.

From surgery through approximately 30 days after surgery
Postoperative Distance Visual Acuity
Lasso di tempo: Day 1 and Day 30 after surgery

Distance visual acuity will be assessed after cataract surgery and compared between the illuminated chopper and conventional microscope illumination conditions.

Day 1 and Day 30 after surgery
Postoperative Intraocular Pressure
Lasso di tempo: Day 1 and Day 30 after surgery

Intraocular pressure will be assessed during postoperative follow-up and compared between the illuminated chopper and conventional microscope illumination conditions.

Day 1 and Day 30 after surgery

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Incidence of Adverse Events
Lasso di tempo: From surgery through approximately 30 days after surgery

The incidence of adverse events following cataract surgery will be assessed, including cystoid macular edema, endophthalmitis, lens luxation, pupillary block, retinal detachment, and persistent elevation of intraocular pressure requiring treatment.

From surgery through approximately 30 days after surgery
Incidence of Postoperative Ocular Complications
Lasso di tempo: From surgery through approximately 30 days after surgery

Ocular complications will be assessed, including flat anterior chamber, vitreous in the anterior chamber, residual lens material, intraocular lens decentration or tilt, posterior capsular fibrosis or opacity, and intraocular pressure elevation requiring treatment.

From surgery through approximately 30 days after surgery

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Direttore dello studio: Dong Heun Nam, MD, PhD, Gachon University Gil Medical Center, College of Medicine, Incheon, Republic of Korea

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

14 settembre 2023

Completamento primario (Effettivo)

7 marzo 2024

Completamento dello studio (Effettivo)

7 marzo 2024

Date di iscrizione allo studio

Primo inviato

19 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

19 settembre 2026

Primo Inserito (Effettivo)

25 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

2 ottobre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

28 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • OCL-IIC-01
  • RS-2022-00141533 (Altro numero di sovvenzione/finanziamento: The Korean government (the Ministry of Science and ICT; the Ministry of Trade, Industry, and Energy))

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

De-identified individual participant data may be shared with qualified researchers upon reasonable request after publication, subject to review by the study investigators and sponsor and in accordance with applicable ethical, privacy, and regulatory requirements.

Periodo di condivisione IPD

Beginning after publication of the primary study results and available for 5 years thereafter.

Criteri di accesso alla condivisione IPD

Data will be made available to qualified researchers who submit a reasonable and scientifically sound request. Requests will be reviewed by the study investigators and sponsor. Access will be provided for approved research purposes, subject to appropriate data use agreements and compliance with applicable ethical, privacy, and regulatory requirements.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

Sì

prodotto fabbricato ed esportato dagli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .